Category Archives: Liquid Biopsy & Circulating Nucleic Acids

Biological, Structural and Functional Aspects of Circulating Nucleic Acids

By Granit Thaqi | July 3, 2023 - 01:40 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Biological, Structural and Functional Aspects of Circulating Nucleic Acids

→

Clinical Applicability of Circulating Nucleic Acids

By Granit Thaqi | July 3, 2023 - 01:38 |July 9, 2023 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Clinical Applicability of Circulating Nucleic Acids

→

Use of Synthetic Reference Sequence Spike-In Controls to Increase Reliability of NGS Testing for Actionable Mutations in Circulating Tumor DNA

By Granit Thaqi | July 3, 2023 - 01:36 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Use of Synthetic Reference Sequence Spike-In Controls to Increase Reliability of NGS Testing for Actionable Mutations in Circulating Tumor DNA

→

Novel NGS-based Proteomics Revolutionizes Biomarker Identification in Liquid Biopsies

By Granit Thaqi | July 3, 2023 - 01:34 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Novel NGS-based Proteomics Revolutionizes Biomarker Identification in Liquid Biopsies

→

Tumour-guided Personalised Sequencing Assays For ctDNA Detection

By Granit Thaqi | July 3, 2023 - 01:32 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Tumour-guided Personalised Sequencing Assays For ctDNA Detection

→

Liquid Biopsies: Optimization and Sample Quality Controls for ctDNA Measurements

By Granit Thaqi | July 3, 2023 - 01:29 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Liquid Biopsies: Optimization and Sample Quality Controls for ctDNA Measurements

→

Two-Tailed PCR for Precision Diagnostics

By Granit Thaqi | July 3, 2023 - 01:26 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Two-Tailed PCR for Precision Diagnostics

→

New Perspectives for Liquid Profiling of Circulating Nucleic Acids in Clinical Diagnostics

By Granit Thaqi | July 3, 2023 - 01:24 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on New Perspectives for Liquid Profiling of Circulating Nucleic Acids in Clinical Diagnostics

→

HepatomiR® – MicroRNA Biomarkers of Liver Function: from Discovery to Implementation as a Diagnostic Test to Support Management of Liver Cancer Patients

By Granit Thaqi | July 3, 2023 - 01:22 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on HepatomiR® – MicroRNA Biomarkers of Liver Function: from Discovery to Implementation as a Diagnostic Test to Support Management of Liver Cancer Patients

→

Performance Evaluation of RNA Purification Kits and Blood Collection Tubes in the Extracellular RNA Quality Control (exRNAQC) Study

By Granit Thaqi | July 3, 2023 - 01:20 |March 24, 2024 GQ2023, Liquid Biopsy & Circulating Nucleic Acids

Comments Off on Performance Evaluation of RNA Purification Kits and Blood Collection Tubes in the Extracellular RNA Quality Control (exRNAQC) Study

→